The concentration of plasma FGF19 was undetectable in both vehicle- and PBS-treated mice (VP mice) and antibiotic- and PBS-treated mice (AP mice), but increased in antibiotic- and FGF19-treated mice (AF) mice (Figure S4). This evidence concerns the gene FGF19 and atrial fibrillation.